COMPARE-II- Vasomotion and Imaging Substudy
NCT01329237 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2011-04-05
Summary
The purpose of the study is to compare strut coverage and neointimal thickness between everolimus eluting (XIENCE-V® or PROMUS® stent) and biolimus A9 eluting NOBORI Stent 14 months after stent implantation and to determine the coronary endothelial function after everolimus eluting (XIENCE-V® or PROMUS® stent) and biolimus A9 eluting NOBORI Stent 14 months after stent implantation by using supine bicycle exercise testing to assess coronary vasomotor response to exercise.
Conditions
Interventions
- OTHER
-
dynamic physical exercise and OCT imaging
supine dynamic physical exercise during coronary angiography and optical coherence tomography OCT imaging of the coronary stent
Sponsors & Collaborators
-
University of Freiburg
lead OTHER
Principal Investigators
-
Mario Togni, MD · University of Fribourg, Switzerland
-
Stéphane Cook, MD · University of Fribourg, Switzerland
-
Jean-Christophe Stauffer, MD · Hopital Cantonal HFR, Fribourg, Switzerland
-
Jean-Jacques Goy, MD · Hopital Cantonal HFR, Fribourg, Switzerland
-
Gérard Baeriswyl, MD · Hopital Cantonal HFR, Fribourg, Switzerland
-
Pieter C Smits, MD, PhD · Maasstad Ziekenhuis, Rotterdam, The Netherlands
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-03-31
- Primary Completion
- 2012-03-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents
NCT01711931 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Stent Strut Coverage and Endothelial Function After Drug-Eluting Stents
NCT01073111 ·Status: WITHDRAWN ·Phase: NA
-
Everolimus- Versus Biolimus-Eluting Stents in All-Comers
NCT01472705 ·Status: COMPLETED
-
Comparison of Biolimus A9 and Everolimus Drug-Eluting Stents in Patients With ST Segment Elevation Myocardial Infarction
NCT00888758 ·Status: UNKNOWN ·Phase: PHASE4
-
Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction
NCT02890589 ·Status: COMPLETED ·Phase: NA
-
Zotarolimus and Everolimus-Eluting Stents ProsPectively Compared in Real World
NCT00768846 ·Status: UNKNOWN ·Phase: PHASE4
-
NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent Trial
NCT01303640 ·Status: COMPLETED ·Phase: PHASE4
-
Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents
NCT01068106 ·Status: UNKNOWN ·Phase: PHASE4
-
Drug-eluting Stents to Treat Unprotected Coronary Left Main Disease
NCT00598637 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Examine the Implantation Characteristics of Two Drug-Eluting Stents
NCT01201369 ·Status: COMPLETED ·Phase: NA
-
Comparison of MECHANISM of Early and Late Vascular Responses Following Treatment of ST-elevation Acute Myocardial Infarction With Two Different Everolimus-eluting Stents: Randomized Controlled Trial Between Biodegradable Polymer and Durable Polymer Stent (MECHANISM-AMI-RCT)
NCT03726892 ·Status: UNKNOWN ·Phase: NA
-
SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System
NCT00180310 ·Status: COMPLETED ·Phase: PHASE3
-
Optical Coherence Tomography for Drug Eluting Stent Safety
NCT00693030 ·Status: UNKNOWN ·Phase: PHASE4
-
Randomized Trial Comparing Titan Stent With Zotarolimus-Eluting Stent
NCT00492908 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention
NCT06692140 ·Status: RECRUITING ·Phase: NA
-
XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS)
NCT02513732 ·Status: COMPLETED
-
Prospective, Randomized, Multicenter Trial to Assess PROMUS™ Element™ Stent
NCT01285999 ·Status: COMPLETED ·Phase: NA
-
StEnt Coverage and Neointimal Tissue Characterization After eXtra Long evErolimus - Eluting Stent imPlantation
NCT03401216 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Neointimal Coverage of EES and BMS After Implantation in STEMI Patients by Optical Coherence Tomography
NCT01875835 ·Status: TERMINATED ·Phase: NA
-
A Randomized Comparison of Long-Term Healing Between Biodegradable- Versus Durable-Polymer Everolimus Eluting Stents in STEMI
NCT03440801 ·Status: COMPLETED ·Phase: NA
-
Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization
NCT01342822 ·Status: UNKNOWN
-
Randomized, Two-arm, Non-inferiority Study Comparing Endeavor-Resolute Stent With Abbot Xience-V Stent
NCT00617084 ·Status: COMPLETED ·Phase: PHASE4
-
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
NCT01498692 ·Status: COMPLETED ·Phase: NA
-
A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
NCT02579031 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis
NCT00598533 ·Status: COMPLETED ·Phase: PHASE4